We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$840B
AUM Growth
-$11.4B
Cap. Flow
+$21.2B
Cap. Flow %
2.53%
Top 10 Hldgs %
26.02%
Holding
4,905
New
147
Increased
3,717
Reduced
626
Closed
142

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.02B
2
AAPL icon
Apple
AAPL
+$837M
3
AMZN icon
Amazon
AMZN
+$811M
4
KVUE icon
Kenvue
KVUE
+$761M
5
BX icon
Blackstone
BX
+$581M

Sector Composition

Rank Sector Weight
1 Technology 27.7%
2 Healthcare 13.07%
3 Financials 12.46%
4 Consumer Discretionary 10.84%
5 Industrials 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPCS icon
3601
TechPrecision Corp
TPCS
$47.7M
$501K ﹤0.01%
68,918
+29,245
+74% +$212K
CULL
3602
DELISTED
Cullman Bancorp Inc.
CULL
$500K ﹤0.01%
46,789
+45
+0.1% +$481
NVNO
3603
enVVeno Medical
NVNO
$7.14M
$500K ﹤0.01%
2,649
+275
+12% +$45.9K
CSPI icon
3604
CSP Inc
CSPI
$82.3M
$500K ﹤0.01%
57,094
+16,268
+40% +$120K
SPRO icon
3605
Spero Therapeutics
SPRO
$66.6M
$500K ﹤0.01%
412,707
+21,902
+6% +$30.3K
LWAY icon
3606
Lifeway Foods
LWAY
$452M
$498K ﹤0.01%
48,128
+5,690
+13% +$49.5K
LEE icon
3607
Lee Enterprises
LEE
$175M
$493K ﹤0.01%
46,012
-5,811
-11% -$70.7K
BGXX
3608
DELISTED
Bright Green Corporation Common Stock
BGXX
$492K ﹤0.01%
1,242,348
-23,892
-2% -$14.9K
CLST icon
3609
Catalyst Bancorp
CLST
$68M
$490K ﹤0.01%
40,151
+3,487
+10% +$41.5K
BYFC icon
3610
Broadway Financial
BYFC
$97.2M
$490K ﹤0.01%
62,438
+1,972
+3% +$15.1K
GANX icon
3611
Gain Therapeutics
GANX
$74.6M
$489K ﹤0.01%
151,476
+12,755
+9% +$48.4K
ACCS
3612
ACCESS Newswire
ACCS
$25.8M
$488K ﹤0.01%
25,949
-974
-4% -$19.7K
CPHC icon
3613
Canterbury Park Holding Corp
CPHC
$78.8M
$488K ﹤0.01%
24,110
+18
+0.1% +$393
HSHP
3614
Himalaya Shipping
HSHP
$751M
$487K ﹤0.01%
100,876
-159,541
-61% -$855K
STRR
3615
Star Equity Holdings
STRR
$39.6M
$484K ﹤0.01%
24,981
+263
+1% +$5.55K
TZOO icon
3616
Travelzoo
TZOO
$75.9M
$483K ﹤0.01%
82,788
-14,568
-15% -$104K
FATBB
3617
DELISTED
FAT Brands
FATBB
$481K ﹤0.01%
117,527
-7,622
-6% -$36.5K
LOAN
3618
Manhattan Bridge Capital
LOAN
$47.9M
$480K ﹤0.01%
100,017
+63
+0.1% +$303
MAG
3619
DELISTED
MAG Silver
MAG
$480K ﹤0.01%
46,409
-882
-2% -$9.81K
EQX icon
3620
Equinox Gold
EQX
$7.24B
$473K ﹤0.01%
112,570
+2,121
+2% +$10.2K
ENZ
3621
DELISTED
Enzo Biochem, Inc.
ENZ
$473K ﹤0.01%
337,856
+281
+0.1% +$424
CULP icon
3622
Culp Inc
CULP
$44.2M
$473K ﹤0.01%
84,697
+1,014
+1% +$5.6K
BIVI icon
3623
BioVie
BIVI
$12.2M
$472K ﹤0.01%
1,384
-131
-9% -$51.2K
PSNY icon
3624
Polestar Automotive Holding UK
PSNY
$2.11B
$472K ﹤0.01%
5,960
+3,529
+145% +$391K
SAND
3625
DELISTED
Sandstorm Gold
SAND
$468K ﹤0.01%
100,067
+1,936
+2% +$10.2K

Similar funds

Geode Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
  • Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
  • Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
  • Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
  • Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
  • Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
  • Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.